Download presentation
Presentation is loading. Please wait.
1
Volume 57, Pages S32-S37 (April 2000)
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy Hendrik Bos, Steen Andersen, Peter Rossing, Dick de Zeeuw, Hans-Henrik Parving, Paul E. de Jong, Gerjan Navis Kidney International Volume 57, Pages S32-S37 (April 2000) DOI: /j x Copyright © 2000 International Society of Nephrology Terms and Conditions
2
Figure 1 Individual antiproteinuric efficacy. In diabetic patients (IDDM), efficacy is presented as percentage change in albuminuria. In nondiabetic patients (NDRD), efficacy is presented as percent change in proteinuria. Symbols are: (•), ACE inhibitor vs. AT1 receptor blockade in IDDM; (▴), ACE inhibitor vs. AT1 receptor blockade in NDRD; (▪), ACE inhibitor vs. NSAID combined with alpha-methyldopa in NDRD. Kidney International , S32-S37DOI: ( /j x) Copyright © 2000 International Society of Nephrology Terms and Conditions
3
Figure 2 Individual antihypertensive efficacy presented as percentage change in diabetic patients (IDDM; •) and in nondiabetic renal disease (NDRD; ▴, ACE inhibitor vs. AT1 receptor blockade; ▪, ACE inhibitor vs. NSAID combined with alpha-methyldopa). Kidney International , S32-S37DOI: ( /j x) Copyright © 2000 International Society of Nephrology Terms and Conditions
4
Figure 3 Individual antiproteinuric responses to the two different doses of ACE inhibitor (A) and AT1 receptor blockade (B) for diabetic (IDDM, •) and nondiabetic patients (▪). The continuous line represents the line of identity. Kidney International , S32-S37DOI: ( /j x) Copyright © 2000 International Society of Nephrology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.